Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Instil Bio, Inc. (TIL) had Stock-Based Compensation of $5.32M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-21.39M |
|
-- |
|
-- |
|
$23.44M |
|
$-23.44M |
|
$2.05M |
|
$-21.39M |
|
$-21.39M |
|
$-21.39M |
|
$-21.39M |
|
$-21.39M |
|
$-21.39M |
|
$-23.44M |
|
$-23.43M |
|
6.60M |
|
6.60M |
|
$-3.24 |
|
$-3.24 |
|
| Balance Sheet Financials | |
$207.39M |
|
$0.15M |
|
$23.60M |
|
$230.99M |
|
$13.85M |
|
$84.42M |
|
$85.46M |
|
$99.32M |
|
$131.67M |
|
$131.67M |
|
$131.67M |
|
6.75M |
|
| Cash Flow Statement Financials | |
$-18.99M |
|
$9.21M |
|
$6.91M |
|
$10.63M |
|
$7.84M |
|
$-2.80M |
|
|
Stock-Based Compensation |
$5.32M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.97 |
|
-- |
|
-- |
|
0.39 |
|
0.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.25% |
|
-16.25% |
|
-9.26% |
|
-9.90% |
|
$19.50 |
|
$-2.88 |
|
$-2.88 |
|